Aldrin: Target Organs and Levels of Evidence for TR-021
Bioassays of Aldrin and Dieldrin for Possible Carcinogenicity (CASRN 309-00-2) (CASRN 60-57-1)
| Chemical (Study Title) CASRN |
Peer Review Date | Route/Exposure Levels | Study Laboratory |
|---|---|---|---|
| Aldrin 309-00-2 |
09/26/1977 | Dosed-Feed R:0,30,60 MM:0,4,8 FM:0,3,6 PPM/50 PER GROUP |
Gulf South Research Institute |
Levels of Evidence
Male Rats: Equivocal
| Type | Organ/Tissue (Lesion) |
|---|---|
| Neoplastic Lesions |
|
Female Rats: Equivocal
| Type | Organ/Tissue (Lesion) |
|---|---|
| Neoplastic Lesions |
|
Male Mice: Positive
| Type | Organ/Tissue (Lesion) |
|---|---|
| Neoplastic Lesions |
|
Female Mice: Negative
| Chemical (Study Title) CASRN |
Peer Review Date | Route/Exposure Levels | Study Laboratory |
|---|---|---|---|
| Dieldrin 60-57-1 |
09/26/1977 | Dosed-Feed R: 0,30,60, M: 0,2.5,5 PPM/50 PER GROUP |
Gulf South Research Institute |
Levels of Evidence
Male Rats: Negative
Female Rats: Negative
Male Mice: Equivocal
| Type | Organ/Tissue (Lesion) |
|---|---|
| Neoplastic Lesions |
|